The successful implementation of transcutaneous CO2 equipment at Hershey Medical Center’s Level IV NICU demonstrates that the technology has evolved to accommodate the diagnostic monitoring needs of neonatal care providers and patients, according to this case study by clinicians in the center's NICU.
International Biophysics Corporation has rebranded its company as Movair to coincide with the US launch of its new critical care ventilator, Luisa.
Boston Scientific has begun enrollment in a clinical trial comparing use of the EkoSonic Endovascular System (EKOS) in combination with anticoagulation to anticoagulation alone for the treatment of acute, intermediate-high-risk pulmonary embolism.
Researchers at the National Institutes of Health have developed a prototype device that could potentially diagnose pregnancy complications by monitoring the oxygen level of the placenta.
Long-term data confirmed the Zephyr Endobronchial Valve provided improvements over baseline in lung function and quality of life out to at least 24 months, and improvements in exercise capacity out to at least 18 months.
In metropolitan areas 72.8% of Medicare beneficiaries with COPD had a pulmonary rehab center within 10 miles, compared with 38.2% in micropolitan and 17.1% in small town and rural areas.